It really is our hope that treatment allows patients with heart disease to enjoy an increased standard of living. Dr. Anne Taylor of the University of Minnesota was the study’s lead author. Other researchers from the Veterans Affairs Medical Center in Washington, D.C., Wake Forest University School of Medicine, Heartbeats Lifestyle Xavier and Center University; the Association of Black NitroMed and Cardiologists, Inc. Also contributed.. A fresh medication has dramatically reduced mortality among African-American patients experiencing heart disease A fresh medication has dramatically reduced mortality among African-American patients experiencing heart disease, according to results of a report including UT Southwestern Medical Center at Dallas researchers. The full total results were therefore favorable that investigators halted the multi-center trial in order that all the 1,050 study participants suffering from advanced heart failure, including those on a placebo, could possibly be given the mixed drug treatment, stated Dr.In daily diaries, parents reported symptoms ,20 medications, healthcare visits, and absences from day preschool or care or parental work. Outcome Measures The primary outcome measure was the frequency of exacerbations, which was defined as the number of courses of an oral glucocorticoid started for severe wheezing after consultation with a physician based on a specific published protocol9,11 through the 12-month treatment period .